Reshape Lifesciences INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Vyome Holdings, Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, a significant reduction in authorized common stock, auditor ratification, and executive compensation.
Vyome Holdings, Inc. announced its 2025 Annual Meeting of Stockholders to vote on director elections, a new equity incentive plan, auditor ratification, and executive compensation.
ReShape Lifesciences is holding a special meeting to seek stockholder approval for a reverse stock split, warrant exercises, and an equity line of credit issuance to meet Nasdaq listing requirements and fund operations.